Point72 Hong Kong LTD Bio N Tech Se Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $3,249 - $5,437	-15 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $1,699 - $3,622	15 New	15 $3,000
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $1,285 - $1,792	-15 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $1,090 - $1,943	15 New	15 $1,000
Q1 2020 May 15, 2020	SELL	$28.55 - $92.0 $499,567 - $1.61 Million	-17,498 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.75 - $36.91 $223,099 - $645,851	17,498 New	17,498 $593,000

363

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.